At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.

We recognize that patients living with immune-mediated diseases need alternatives to currently available therapies. Despite recent advances and innovations in the treatment of immune-mediated diseases, many patients continue to suffer, cycling through currently approved therapies while looking for a solution that alleviates the debilitating impact of their disease without life-limiting side effects. 

Addressing the needs of these patients is why we exist. We are pioneering a precision approach that leverages insights we derive from powerful data analytics to select the right target, right molecule, right indication, right patient, and right endpoint resulting in optimized outcomes for patients. We believe that combining our insights with an integrated approach to drug development will produce the next generation of treatments to address immune dysfunction. 

Incubated by Foresite Labs, Alumis is led by a team of deeply experienced professionals who are devoted to transforming the lives of patients with immune-mediated diseases by developing a pipeline of transformative therapies.

Health Care

Life Sciences

Therapeutics

Alumis

Martin Babler

Melissa Ceo

Grace Halteh

Director, Regulatory Strategy

Lily Gong

Jennifer Cortes

Kolbot By

Derrick Richardson

Tim Owens

Alan Colowick

Roy Hardiman

Mark Bradley

Jörn Drappa

John Schroer

David M Goldstein

The Leadership Team at Alumis is responsible for setting the strategic direction of the company and ensuring the successful execution of its vision to transform the lives of patients with immune-mediated diseases. This team of deeply experienced professionals oversees all aspects of the company's operations, including research and development, clinical development, quality assurance, regulatory affairs, financial management, and people and culture. Their integrated approach aims to innovate and optimize targeted therapies, leveraging powerful data analytics to deliver next-generation treatments that address immune dysfunction with precision and efficacy.

Leadership Team

Clinical and Development Operations

Research and Development

Leadership Team

About

Team members

Other teams at Alumis

Clinical and Development Operations

Research and Development